Alfredo Tartarone

7PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 24, 2026
Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

|Apr 18, 2025
Application of dihydropyrimidine dehydrogenase deficiency testing for the prevention of fluoropyrimidine toxicity: a real-world experience in a Southern Italy cancer center.

Gabriella Bianchino, Alessandra Perrone, Alessandro Sgambato

|May 13, 2022
Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management.

Alfredo Tartarone, Rosa Lerose, Marina Tartarone

|Feb 12, 2022
Management of oligoprogression in non-small cell lung cancer patients.

Alfredo Tartarone, Rosa Lerose, Marina Tartarone

|Aug 09, 2020
COVID-19 and cancer care: what do international guidelines say?

Alfredo Tartarone, Rosa Lerose

|May 31, 2018
Is there a role for immunotherapy in malignant pleural mesothelioma?

Alfredo Tartarone, Rosa Lerose, Michele Aieta

Pageof 2

Frequent Collaborators